MURRIETA, CA--(Marketwire - November 19, 2008) - CLX Medical, Inc. (OTCBB: CLXN), which is focused on the marketing and distribution of unique medical diagnostic testing products, today updated the status of the pending close of the company's acquisition of ThyroTest® through the issuance of preferred stock and a note in the amount of $750,000.
